Browse by author
Lookup NU author(s): Professor Akane Kawamura
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. The natural product tripartin has been reported to inhibit the N-methyl-lysine histone demethylase KDM4A. A synthesis of tripartin starting from 3,5-dimethoxyphenylacrylic acid was developed, and the enantiomers were separated by chiral HPLC. We observed that both tripartin enantiomers manifested an apparent increase in H3K9me3 levels when dosed in cells, as measured by western blot analysis. Thus, there is no enantiomeric discrimination toward this natural product in terms of its effects on cellular histone methylation status. Interestingly, tripartin did not inhibit isolated KDM4A–E under our assay conditions (IC50>100 μm). Tripartin analogues with a dichloromethylcarbinol group derived from the indanone scaffold were synthesized and found to be inactive against isolated recombinant KDM4 enzymes and in cell-based assays. Although the precise cellular mode of action of tripartin is unclear, our evidence suggests that it may affect histone methylation status via a mechanism other than direct inhibition of the KDM4 histone demethylases.
Author(s): Guillade L, Sarno F, Tarhonskaya H, Nebbioso A, Alvarez S, Kawamura A, Schofield CJ, Altucci L, de Lera AR
Publication type: Article
Publication status: Published
Print publication date: 19/09/2018
Online publication date: 26/07/2018
Acceptance date: 19/07/2018
ISSN (print): 1860-7179
ISSN (electronic): 1860-7187
Publisher: John Wiley and Sons Ltd
PubMed id: 30047603
Altmetrics provided by Altmetric